Notice2022-03709
Agency Forms Undergoing Paperwork Reduction Act Review
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 22, 2022
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 35 (Tuesday, February 22, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 35 (Tuesday, February 22, 2022)]
[Notices]
[Pages 9622-9623]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-03709]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-22-1268]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Drug Overdose Surveillance and Epidemiology
(DOSE)'' to the Office of Management and Budget (OMB) for review and
approval. CDC previously published a ``Proposed Data Collection
Submitted for Public Comment and Recommendations'' notice on April 26,
2021, to obtain comments from the public and affected agencies. CDC
received four comments related to the previous notice. This notice
serves to allow an additional 30 days for public and affected agency
comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Drug Overdose Surveillance and Epidemiology (DOSE) (OMB Control No.
0920-1268, Exp. 8/31/2022)--Revision--National Center for Injury
Prevention and Control (NCIPC), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
In 2020, a total of 91,799 drug overdose deaths occurred,
corresponding to an age-adjusted rate of 28.3 per 100,000 population
and a 31% increase from the 2019 rate (21.6). From 2013 to 2019, the
synthetic opioid-involved death rate increased 1,040%, from 1.0 to 11.4
per 100,000 age-adjusted (3,105 to 36,359). The psychostimulant-
involved death rate increased 317%, from 1.2 (3,627) in 2013 to 5.0
(16,167) in 2019. Non-fatal overdoses are on the rise as well;
Emergency Department (ED) data from DOSE indicates increases from 2018
to present. In response to the growing severity of the opioid overdose
epidemic, the U.S. government declared the opioid overdose epidemic a
public health emergency on October 26, 2017. The opioid overdose
epidemic is one of the top priorities of the U.S. Department of Health
and Human Services (HHS). In
[[Page 9623]]
2021, HHS expanded their Overdose Prevention Strategy to focus on four
strategic priorities: Primary prevention, harm reduction, evidence-
based treatment, and recovery support.
DOSE is a critical element of HHS's first goal under primary
prevention to support research and surveillance to collect timelier and
more specific data through accelerating the speed at which CDC reports
drug overdose data. DOSE data collection integrates, expands, and
enhances previous data sharing efforts with public health departments
initiated under ESOOS. The goal of DOSE is to conduct surveillance of
approximately 75% of all ED visits for drug overdoses through the end
of the Overdose Data to Action (OD2A) cooperative agreement in 2023. In
2019, OD2A provided funding for 66 jurisdictions; 47 states and the
District of Columbia share data with DOSE. Though we had hoped to
capture data from all 50 states and the District of Columbia, only 47
states and the District of Columbia applied for this funding
announcement.
Currently, DOSE operates in the 47 states and the District of
Columbia currently funded by OD2A (three states did not request CDC
funding in the current cycle but may for the next funding cycle in
2023). Of these 48 health departments, 43 share syndromic data with CDC
monthly and 26 share at least quarterly discharge data. A total of 33
health departments provide CDC with access to their syndromic
surveillance data from EDs in CDC's National Syndromic Surveillance
Program (NSSP) system. Access to this timely data has allowed us to
improve the situational awareness of federal, state, and local health
departments about emerging drug overdose outbreaks and the progression
of the opioid overdose epidemic. Health departments have used this data
to populate state data dashboards and develop alerts for local
communities. In addition, health departments have used this data in
concert with public safety partners to gain a better overall picture of
outbreaks in their communities.
All data sharing between CDC and health departments in DOSE is
driven by two standardized data forms, the Rapid ED overdose data form
and the ED discharge overdose data form, and CDC cases definitions of
drug, opioid, heroin, fentanyl, all stimulant, cocaine,
methamphetamine, benzodiazepine, and other emerging drug overdoses. The
Rapid ED Overdose Data Form will be submitted to CDC monthly. For 35
respondents, the estimated burden per response is 30 minutes. For 10
respondents, the estimated burden per response is three hours. The
estimated burden per response for the ED Discharge Overdose Data Form
is three hours. This form will be submitted four times per year by 28
respondents and once per year by 23 respondents. All information will
be collected electronically. The total estimated annualized burden
hours are 975.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response
respondents respondent (hours)
----------------------------------------------------------------------------------------------------------------
Participating health departments Rapid ED overdose data 10 12 3
sharing aggregate data from local form.
syndromic or hospital discharge file.
Participating health departments Rapid ED overdose data 35 12 30/60
sharing case-level ED data with CDC form.
through the NSSP BioSense (OMB No.
0920-0824).
Participating health department ED discharge overdose 28 4 3
sharing finalized hospital discharge data form.
data on a quarterly basis.
Participating health department ED discharge overdose 23 1 3
sharing finalized hospital discharge data form.
data on a yearly basis.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-03709 Filed 2-18-22; 8:45 am]
BILLING CODE 4163-19-P
</pre></body>
</html>Indexed from Federal Register on February 22, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.